Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha
- PMID: 19359588
- PMCID: PMC3251015
- DOI: 10.1126/science.1170944
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha
Abstract
Heterozygous mutations in the gene encoding isocitrate dehydrogenase-1 (IDH1) occur in certain human brain tumors, but their mechanistic role in tumor development is unknown. We have shown that tumor-derived IDH1 mutations impair the enzyme's affinity for its substrate and dominantly inhibit wild-type IDH1 activity through the formation of catalytically inactive heterodimers. Forced expression of mutant IDH1 in cultured cells reduces formation of the enzyme product, alpha-ketoglutarate (alpha-KG), and increases the levels of hypoxia-inducible factor subunit HIF-1alpha, a transcription factor that facilitates tumor growth when oxygen is low and whose stability is regulated by alpha-KG. The rise in HIF-1alpha levels was reversible by an alpha-KG derivative. HIF-1alpha levels were higher in human gliomas harboring an IDH1 mutation than in tumors without a mutation. Thus, IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.
Figures




Comment in
-
Cancer. Puzzling patterns of predisposition.Science. 2009 Apr 10;324(5924):192-4. doi: 10.1126/science.1173362. Science. 2009. PMID: 19359573 No abstract available.
Similar articles
-
Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.J Mol Neurosci. 2012 Jul;47(3):442-7. doi: 10.1007/s12031-011-9681-5. Epub 2011 Nov 24. J Mol Neurosci. 2012. PMID: 22113362
-
Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.Aging (Albany NY). 2021 Jan 20;13(3):3645-3660. doi: 10.18632/aging.202328. Epub 2021 Jan 20. Aging (Albany NY). 2021. PMID: 33493139 Free PMC article.
-
[Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].Zhonghua Bing Li Xue Za Zhi. 2013 May;42(5):292-8. doi: 10.3760/cma.j.issn.0529-5807.2013.05.002. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24004584 Chinese.
-
Glioma-derived mutations in IDH: from mechanism to potential therapy.Biochem Biophys Res Commun. 2010 Jun 25;397(2):127-30. doi: 10.1016/j.bbrc.2010.05.115. Epub 2010 May 27. Biochem Biophys Res Commun. 2010. PMID: 20510884 Review.
-
Isocitrate dehydrogenase mutations in gliomas.Neuro Oncol. 2016 Jan;18(1):16-26. doi: 10.1093/neuonc/nov136. Epub 2015 Jul 16. Neuro Oncol. 2016. PMID: 26188014 Free PMC article. Review.
Cited by
-
Dendritic cell SIRT1-HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1.Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):E957-65. doi: 10.1073/pnas.1420419112. Epub 2015 Feb 17. Proc Natl Acad Sci U S A. 2015. PMID: 25730867 Free PMC article.
-
Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations.Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221139262. doi: 10.1177/03946320221139262. Int J Immunopathol Pharmacol. 2022. PMID: 36377597 Free PMC article.
-
Cancer genome landscapes.Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122. Science. 2013. PMID: 23539594 Free PMC article. Review.
-
Identification of a new selective chemical inhibitor of mutant isocitrate dehydrogenase-1.J Cancer Prev. 2015 Mar;20(1):78-83. doi: 10.15430/JCP.2015.20.1.78. J Cancer Prev. 2015. PMID: 25853107 Free PMC article.
-
Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer.Front Cell Dev Biol. 2021 Apr 27;9:654337. doi: 10.3389/fcell.2021.654337. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33987181 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous